Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accuracy of Blood-based Biomarkers in Diagnosing Alzheimer's Disease in Clinical Practice

NCT05187819 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.

NCT NCT05187819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05187819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accuracy of Blood-based Biomarkers in Diagnosing Alzheimer's Disease in Clinical Practice
Lead sponsor
Helse Stavanger HF
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2023
Completion date
December 31, 2029
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia alzheimers